Here, VDR refers to training about veterinary device regulation, not the title of one veterinary device regulation applicable worldwide. Identify the intended animal use and target market first.
MDR’s scope for human use cannot automatically be applied to a veterinary product. Examine the target country’s applicable veterinary, electrical, radio, machinery or other product rules separately. Training should begin with intended purpose and principal features. Adapting a human-use device does not remove the need to assess the new use.
Compare the product’s principal action, composition and claims with the relevant country’s definitions. Medicines, biological products and devices may follow different routes. Commercially calling a product a device is insufficient. Training should distinguish equipment with a physical function from a product relying on an active substance and identify the specialist review needed.
FDA explains that devices intended solely for animal use do not generally follow a premarket approval route. This does not remove responsibility for safety and proper labelling. Training should focus on actual product obligations rather than an approval claim. Products also intended for human use require separate assessment.
Assess radiation, electrical and operator safety characteristics separately. Target-country rules for the device, facility and its use may assign duties to different parties. Training should distinguish information required from manufacturers, importers and clinical users. An animal-use label does not replace technical safety evaluation.
Reassess size, loading, physiological use conditions, user skills and expected performance. Justify whether earlier evidence represents the new species. Instructions and risk information may also be affected. Training should show why extending the species or use is more than changing marketing wording.
A training certificate is not a product licence, market authorisation or universal acceptance document. Check actual target-market requirements and product scope separately. Review the existing file when the country or distributor changes. To scope training, provide the product definition, intended countries and the commercial role being undertaken.
Use a scenario to collect product identity, target species, use conditions and event information. Assign immediate risk containment and the relevant country’s reporting route to authorised roles. Training addresses organisational records, technical investigation and communication rather than prescribing clinical treatment. Do not use real customer data without anonymising it.
Content reviewed:
Share the subject, organisation or product, target market, current evidence and target date. The team can then separate consultancy, official fees, independent evaluation and realistic timing.
TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский